# A Study of Radiation With Sorafenib in Advanced Cancer

> **NCT00610246** · PHASE1 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 34 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT00610246
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-12
- **Final completion:** 2011-05
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00610246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00610246, "A Study of Radiation With Sorafenib in Advanced Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00610246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*